The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

Hedge fund Rubicon Founders increased its stake in Privia Health Group by 175,142 shares in Q1 2026, with the stock now representing 88.92% of the fund's portfolio. The move signals bullish sentiment, supported by Privia's strong financial performance including 26% YoY revenue growth in Q1 2026 and 59% net income growth in 2025, positioning it as a worthwhile long-term investment.

Cross Keys Capital served as exclusive financial advisor to the Neurology Group of Bergen County (NGBC) in its partnership with Privia Health. NGBC, a 50-year-old independent neurology practice in New Jersey with 25 clinicians, partnered with Privia to expand access to neurological care while maintaining its independent culture. The transaction terms were not disclosed.

Privia Health Group announced a definitive agreement to expand into New Jersey through a partnership with Neurology Group of Bergen County (NGBC), a 25-clinician neurology practice. NGBC will serve as the anchor practice for Privia Medical Group—New Jersey and is expected to be implemented on the Privia Platform by year-end 2026. The partnership aims to provide community clinicians with resources and support while maintaining NGBC's independent culture.

Privia Health Group announced Q1 2026 financial results showing strong performance with total revenue of $603.8M (up 25.8% YoY), practice collections of $914.8M (up 14.6%), and adjusted EBITDA of $36.7M (up 36.3%). The company maintained most of its full-year 2026 guidance while raising attributed lives guidance to 1.6-1.625 billion. Key operational metrics showed growth in implemented providers (5,535, up 13.6%) and attributed lives (1.606M, up 26.5%).

Privia Health Group's CFO David Mountcastle sold 13,018 shares worth approximately $283,000 over March 12-13, 2026, to cover tax obligations from vesting stock units. The sale represented 5.24% of his direct holdings. Despite a 10% stock price decline in 2026, the company reported strong Q4 FY2025 earnings, exceeding expectations with 7 cents per share, and remains optimistic about its ACO acquisition that added 1.5 million customers.

Privia Health's Accountable Care Organizations achieved $233.1 million in shared savings for 2024, a 32% increase from 2023, managing over $2.5 billion in healthcare benchmark spend across 3,280 providers serving approximately 194,700 Medicare beneficiaries.

Privia Health reported strong Q2 2025 financial performance with 23.4% revenue growth, raised full-year guidance, and expanded to 5,125 implemented providers across 15 states.

Privia Health Group, Inc. reported strong financial results for the first quarter of 2025, with increases in revenue, gross profit, operating income, and net income. The company also announced its expansion into the state of Arizona through a partnership with Integrated Medical Services, one of the largest independent multi-specialty practices in the state.

Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will release its fourth quarter and full-year 2024 financial results on February 27, 2025, and host a conference call to discuss the results.

The U.S. primary care physicians market is expected to grow by $46.15 billion from 2022-2027, driven by demographic shifts, healthcare access, and the increasing prevalence of chronic diseases. Key trends include telehealth integration, patient-centered medical homes, and digital health adoption.

Privia Health to Participate in the William Blair Growth Stock Conference